nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1B1—ovarian cancer	0.275	0.597	CbGaD
Melatonin—ESR1—ovarian cancer	0.185	0.403	CbGaD
Melatonin—MPO—Carboplatin—ovarian cancer	0.079	0.304	CbGbCtD
Melatonin—CYP1B1—Paclitaxel—ovarian cancer	0.0558	0.214	CbGbCtD
Melatonin—CYP19A1—Paclitaxel—ovarian cancer	0.0452	0.174	CbGbCtD
Melatonin—CYP1B1—Docetaxel—ovarian cancer	0.0403	0.155	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—ovarian cancer	0.0301	0.116	CbGbCtD
Melatonin—CYP2C9—Paclitaxel—ovarian cancer	0.00985	0.0379	CbGbCtD
Melatonin—CYP19A1—follicular fluid—ovarian cancer	0.0092	0.0991	CbGeAlD
Melatonin—CYP19A1—corpus luteum—ovarian cancer	0.0053	0.0571	CbGeAlD
Melatonin—CALR—oviduct—ovarian cancer	0.00514	0.0553	CbGeAlD
Melatonin—CYP19A1—ovarian follicle—ovarian cancer	0.00415	0.0446	CbGeAlD
Melatonin—ESR1—ovarian follicle—ovarian cancer	0.0036	0.0388	CbGeAlD
Melatonin—EPX—female reproductive system—ovarian cancer	0.00216	0.0232	CbGeAlD
Melatonin—EPX—bone marrow—ovarian cancer	0.00204	0.0219	CbGeAlD
Melatonin—ASMT—gonad—ovarian cancer	0.002	0.0215	CbGeAlD
Melatonin—ASMT—female reproductive system—ovarian cancer	0.00179	0.0192	CbGeAlD
Melatonin—CALR—myometrium—ovarian cancer	0.00164	0.0177	CbGeAlD
Melatonin—IDO1—female reproductive system—ovarian cancer	0.00163	0.0176	CbGeAlD
Melatonin—ESR1—oviduct—ovarian cancer	0.00158	0.017	CbGeAlD
Melatonin—CALR—embryo—ovarian cancer	0.00158	0.017	CbGeAlD
Melatonin—CALM2—oviduct—ovarian cancer	0.00157	0.0169	CbGeAlD
Melatonin—ASMT—testis—ovarian cancer	0.00144	0.0155	CbGeAlD
Melatonin—CALR—epithelium—ovarian cancer	0.00129	0.0139	CbGeAlD
Melatonin—CALR—uterine cervix—ovarian cancer	0.00128	0.0138	CbGeAlD
Melatonin—CALR—decidua—ovarian cancer	0.00122	0.0131	CbGeAlD
Melatonin—MTNR1A—testis—ovarian cancer	0.00117	0.0126	CbGeAlD
Melatonin—CALR—endometrium—ovarian cancer	0.00116	0.0125	CbGeAlD
Melatonin—CALR—gonad—ovarian cancer	0.00107	0.0115	CbGeAlD
Melatonin—CALR—uterus—ovarian cancer	0.00107	0.0115	CbGeAlD
Melatonin—MT3—testis—ovarian cancer	0.00098	0.0106	CbGeAlD
Melatonin—CALR—female reproductive system—ovarian cancer	0.000958	0.0103	CbGeAlD
Melatonin—IDO1—lymph node—ovarian cancer	0.000956	0.0103	CbGeAlD
Melatonin—NQO2—myometrium—ovarian cancer	0.000927	0.00998	CbGeAlD
Melatonin—CALR—bone marrow—ovarian cancer	0.000904	0.00974	CbGeAlD
Melatonin—CALR—female gonad—ovarian cancer	0.000872	0.00939	CbGeAlD
Melatonin—CALR—vagina—ovarian cancer	0.000866	0.00933	CbGeAlD
Melatonin—CALR—testis—ovarian cancer	0.000773	0.00832	CbGeAlD
Melatonin—NQO2—uterine cervix—ovarian cancer	0.000721	0.00777	CbGeAlD
Melatonin—MT3—lymph node—ovarian cancer	0.00071	0.00765	CbGeAlD
Melatonin—NQO2—decidua—ovarian cancer	0.000687	0.0074	CbGeAlD
Melatonin—NQO2—endometrium—ovarian cancer	0.000652	0.00702	CbGeAlD
Melatonin—CALM3—myometrium—ovarian cancer	0.000641	0.0069	CbGeAlD
Melatonin—NQO2—uterus—ovarian cancer	0.000601	0.00647	CbGeAlD
Melatonin—CALR—lymph node—ovarian cancer	0.00056	0.00603	CbGeAlD
Melatonin—MPO—epithelium—ovarian cancer	0.00056	0.00603	CbGeAlD
Melatonin—NQO2—female reproductive system—ovarian cancer	0.00054	0.00582	CbGeAlD
Melatonin—NQO2—bone marrow—ovarian cancer	0.00051	0.00549	CbGeAlD
Melatonin—ESR1—myometrium—ovarian cancer	0.000507	0.00545	CbGeAlD
Melatonin—CALM2—myometrium—ovarian cancer	0.000503	0.00542	CbGeAlD
Melatonin—CALM1—myometrium—ovarian cancer	0.000501	0.0054	CbGeAlD
Melatonin—CALM3—uterine cervix—ovarian cancer	0.000499	0.00537	CbGeAlD
Melatonin—NQO2—female gonad—ovarian cancer	0.000492	0.00529	CbGeAlD
Melatonin—NQO2—vagina—ovarian cancer	0.000489	0.00526	CbGeAlD
Melatonin—ESR1—embryo—ovarian cancer	0.000487	0.00525	CbGeAlD
Melatonin—CALM2—embryo—ovarian cancer	0.000484	0.00521	CbGeAlD
Melatonin—CALM1—embryo—ovarian cancer	0.000482	0.00519	CbGeAlD
Melatonin—CALM3—decidua—ovarian cancer	0.000475	0.00512	CbGeAlD
Melatonin—CALM3—endometrium—ovarian cancer	0.000451	0.00486	CbGeAlD
Melatonin—NQO2—testis—ovarian cancer	0.000436	0.0047	CbGeAlD
Melatonin—CALM3—uterus—ovarian cancer	0.000416	0.00448	CbGeAlD
Melatonin—CYP19A1—endometrium—ovarian cancer	0.00041	0.00442	CbGeAlD
Melatonin—CYP1B1—decidua—ovarian cancer	0.000404	0.00435	CbGeAlD
Melatonin—ESR1—epithelium—ovarian cancer	0.000398	0.00428	CbGeAlD
Melatonin—CALM2—epithelium—ovarian cancer	0.000395	0.00426	CbGeAlD
Melatonin—ESR1—uterine cervix—ovarian cancer	0.000394	0.00424	CbGeAlD
Melatonin—CALM1—epithelium—ovarian cancer	0.000393	0.00424	CbGeAlD
Melatonin—MPO—bone marrow—ovarian cancer	0.000393	0.00423	CbGeAlD
Melatonin—CALM2—uterine cervix—ovarian cancer	0.000392	0.00422	CbGeAlD
Melatonin—CALM1—uterine cervix—ovarian cancer	0.00039	0.0042	CbGeAlD
Melatonin—CYP19A1—gonad—ovarian cancer	0.00038	0.0041	CbGeAlD
Melatonin—CYP19A1—uterus—ovarian cancer	0.000378	0.00407	CbGeAlD
Melatonin—ESR1—decidua—ovarian cancer	0.000376	0.00404	CbGeAlD
Melatonin—CALM2—decidua—ovarian cancer	0.000373	0.00402	CbGeAlD
Melatonin—CALM1—decidua—ovarian cancer	0.000372	0.004	CbGeAlD
Melatonin—ESR1—endometrium—ovarian cancer	0.000357	0.00384	CbGeAlD
Melatonin—CYP1B1—gonad—ovarian cancer	0.000356	0.00383	CbGeAlD
Melatonin—CALM2—endometrium—ovarian cancer	0.000354	0.00382	CbGeAlD
Melatonin—CYP1B1—uterus—ovarian cancer	0.000353	0.00381	CbGeAlD
Melatonin—CALM3—bone marrow—ovarian cancer	0.000353	0.0038	CbGeAlD
Melatonin—CALM1—endometrium—ovarian cancer	0.000353	0.0038	CbGeAlD
Melatonin—CALM3—female gonad—ovarian cancer	0.00034	0.00366	CbGeAlD
Melatonin—CYP19A1—female reproductive system—ovarian cancer	0.00034	0.00366	CbGeAlD
Melatonin—CALM3—vagina—ovarian cancer	0.000338	0.00364	CbGeAlD
Melatonin—MPO—testis—ovarian cancer	0.000336	0.00361	CbGeAlD
Melatonin—ESR1—gonad—ovarian cancer	0.000331	0.00356	CbGeAlD
Melatonin—CALM2—gonad—ovarian cancer	0.000329	0.00354	CbGeAlD
Melatonin—ESR1—uterus—ovarian cancer	0.000329	0.00354	CbGeAlD
Melatonin—CALM1—gonad—ovarian cancer	0.000327	0.00352	CbGeAlD
Melatonin—CALM2—uterus—ovarian cancer	0.000327	0.00352	CbGeAlD
Melatonin—CALM1—uterus—ovarian cancer	0.000325	0.0035	CbGeAlD
Melatonin—CYP1B1—female reproductive system—ovarian cancer	0.000318	0.00342	CbGeAlD
Melatonin—NQO2—lymph node—ovarian cancer	0.000316	0.0034	CbGeAlD
Melatonin—CYP19A1—female gonad—ovarian cancer	0.000309	0.00333	CbGeAlD
Melatonin—CYP1A1—epithelium—ovarian cancer	0.000302	0.00326	CbGeAlD
Melatonin—CALM3—testis—ovarian cancer	0.000302	0.00325	CbGeAlD
Melatonin—CYP1A1—uterine cervix—ovarian cancer	0.0003	0.00323	CbGeAlD
Melatonin—ESR1—female reproductive system—ovarian cancer	0.000295	0.00318	CbGeAlD
Melatonin—CALM2—female reproductive system—ovarian cancer	0.000294	0.00316	CbGeAlD
Melatonin—CALM1—female reproductive system—ovarian cancer	0.000292	0.00315	CbGeAlD
Melatonin—CYP1B1—female gonad—ovarian cancer	0.000289	0.00311	CbGeAlD
Melatonin—CALM2—bone marrow—ovarian cancer	0.000277	0.00298	CbGeAlD
Melatonin—CALM1—bone marrow—ovarian cancer	0.000276	0.00297	CbGeAlD
Melatonin—CYP19A1—testis—ovarian cancer	0.000274	0.00295	CbGeAlD
Melatonin—ESR1—female gonad—ovarian cancer	0.000269	0.00289	CbGeAlD
Melatonin—CALM2—female gonad—ovarian cancer	0.000267	0.00288	CbGeAlD
Melatonin—ESR1—vagina—ovarian cancer	0.000267	0.00288	CbGeAlD
Melatonin—CALM1—female gonad—ovarian cancer	0.000266	0.00286	CbGeAlD
Melatonin—CALM2—vagina—ovarian cancer	0.000265	0.00286	CbGeAlD
Melatonin—CALM1—vagina—ovarian cancer	0.000264	0.00285	CbGeAlD
Melatonin—CYP1B1—testis—ovarian cancer	0.000256	0.00276	CbGeAlD
Melatonin—CYP2C19—vagina—ovarian cancer	0.000252	0.00271	CbGeAlD
Melatonin—CYP1A1—uterus—ovarian cancer	0.00025	0.00269	CbGeAlD
Melatonin—MPO—lymph node—ovarian cancer	0.000243	0.00262	CbGeAlD
Melatonin—ESR1—testis—ovarian cancer	0.000238	0.00257	CbGeAlD
Melatonin—CALM2—testis—ovarian cancer	0.000237	0.00255	CbGeAlD
Melatonin—CALM1—testis—ovarian cancer	0.000236	0.00254	CbGeAlD
Melatonin—CYP1A1—female reproductive system—ovarian cancer	0.000225	0.00242	CbGeAlD
Melatonin—CALM3—lymph node—ovarian cancer	0.000219	0.00235	CbGeAlD
Melatonin—CYP2C9—female reproductive system—ovarian cancer	0.000216	0.00233	CbGeAlD
Melatonin—CYP1A1—female gonad—ovarian cancer	0.000204	0.0022	CbGeAlD
Melatonin—CYP1A1—vagina—ovarian cancer	0.000203	0.00219	CbGeAlD
Melatonin—CYP19A1—lymph node—ovarian cancer	0.000199	0.00214	CbGeAlD
Melatonin—CYP1B1—lymph node—ovarian cancer	0.000186	0.002	CbGeAlD
Melatonin—ESR1—lymph node—ovarian cancer	0.000173	0.00186	CbGeAlD
Melatonin—CALM2—lymph node—ovarian cancer	0.000172	0.00185	CbGeAlD
Melatonin—CALM1—lymph node—ovarian cancer	0.000171	0.00184	CbGeAlD
Melatonin—Lethargy—Epirubicin—ovarian cancer	0.000155	0.0018	CcSEcCtD
Melatonin—Back pain—Paclitaxel—ovarian cancer	0.000155	0.0018	CcSEcCtD
Melatonin—Urinary tract disorder—Docetaxel—ovarian cancer	0.000154	0.00179	CcSEcCtD
Melatonin—Muscle spasms—Paclitaxel—ovarian cancer	0.000154	0.00179	CcSEcCtD
Melatonin—Abdominal pain—Vinorelbine—ovarian cancer	0.000153	0.00178	CcSEcCtD
Melatonin—Connective tissue disorder—Docetaxel—ovarian cancer	0.000153	0.00178	CcSEcCtD
Melatonin—Urethral disorder—Docetaxel—ovarian cancer	0.000152	0.00178	CcSEcCtD
Melatonin—Hyponatraemia—Epirubicin—ovarian cancer	0.000152	0.00177	CcSEcCtD
Melatonin—Pain in extremity—Epirubicin—ovarian cancer	0.000152	0.00177	CcSEcCtD
Melatonin—Nausea—Chlorambucil—ovarian cancer	0.000151	0.00176	CcSEcCtD
Melatonin—Vision blurred—Paclitaxel—ovarian cancer	0.000151	0.00175	CcSEcCtD
Melatonin—Hot flush—Doxorubicin—ovarian cancer	0.00015	0.00175	CcSEcCtD
Melatonin—Dizziness—Topotecan—ovarian cancer	0.00015	0.00174	CcSEcCtD
Melatonin—Affect lability—Epirubicin—ovarian cancer	0.000149	0.00174	CcSEcCtD
Melatonin—Migraine—Epirubicin—ovarian cancer	0.000149	0.00174	CcSEcCtD
Melatonin—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000149	0.00173	CcSEcCtD
Melatonin—Agitation—Paclitaxel—ovarian cancer	0.000147	0.00171	CcSEcCtD
Melatonin—Angioedema—Paclitaxel—ovarian cancer	0.000146	0.0017	CcSEcCtD
Melatonin—Eye disorder—Docetaxel—ovarian cancer	0.000145	0.00169	CcSEcCtD
Melatonin—Cardiac disorder—Docetaxel—ovarian cancer	0.000144	0.00168	CcSEcCtD
Melatonin—Vomiting—Topotecan—ovarian cancer	0.000144	0.00168	CcSEcCtD
Melatonin—Mood swings—Epirubicin—ovarian cancer	0.000144	0.00167	CcSEcCtD
Melatonin—Vertigo—Paclitaxel—ovarian cancer	0.000144	0.00167	CcSEcCtD
Melatonin—Syncope—Paclitaxel—ovarian cancer	0.000143	0.00167	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—ovarian cancer	0.000143	0.00167	CcSEcCtD
Melatonin—Leukopenia—Paclitaxel—ovarian cancer	0.000143	0.00166	CcSEcCtD
Melatonin—Rash—Topotecan—ovarian cancer	0.000143	0.00166	CcSEcCtD
Melatonin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000143	0.00166	CcSEcCtD
Melatonin—Dermatitis—Topotecan—ovarian cancer	0.000143	0.00166	CcSEcCtD
Melatonin—Headache—Topotecan—ovarian cancer	0.000142	0.00165	CcSEcCtD
Melatonin—Palpitations—Paclitaxel—ovarian cancer	0.000141	0.00164	CcSEcCtD
Melatonin—Angiopathy—Docetaxel—ovarian cancer	0.000141	0.00164	CcSEcCtD
Melatonin—Vomiting—Melphalan—ovarian cancer	0.000141	0.00164	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—ovarian cancer	0.000141	0.00164	CcSEcCtD
Melatonin—Immune system disorder—Docetaxel—ovarian cancer	0.00014	0.00164	CcSEcCtD
Melatonin—Loss of consciousness—Paclitaxel—ovarian cancer	0.00014	0.00163	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—ovarian cancer	0.00014	0.00163	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—ovarian cancer	0.00014	0.00163	CcSEcCtD
Melatonin—Rash—Melphalan—ovarian cancer	0.00014	0.00163	CcSEcCtD
Melatonin—Dermatitis—Melphalan—ovarian cancer	0.00014	0.00163	CcSEcCtD
Melatonin—Asthenia—Vinorelbine—ovarian cancer	0.000139	0.00162	CcSEcCtD
Melatonin—Dry skin—Epirubicin—ovarian cancer	0.000139	0.00162	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—ovarian cancer	0.000139	0.00161	CcSEcCtD
Melatonin—Migraine—Doxorubicin—ovarian cancer	0.000138	0.00161	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—ovarian cancer	0.000138	0.00161	CcSEcCtD
Melatonin—Hypertension—Paclitaxel—ovarian cancer	0.000138	0.00161	CcSEcCtD
Melatonin—Pruritus—Vinorelbine—ovarian cancer	0.000137	0.0016	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—ovarian cancer	0.000137	0.0016	CcSEcCtD
Melatonin—Mental disorder—Docetaxel—ovarian cancer	0.000136	0.00159	CcSEcCtD
Melatonin—Arthralgia—Paclitaxel—ovarian cancer	0.000136	0.00158	CcSEcCtD
Melatonin—Chest pain—Paclitaxel—ovarian cancer	0.000136	0.00158	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—ovarian cancer	0.000136	0.00158	CcSEcCtD
Melatonin—Anxiety—Paclitaxel—ovarian cancer	0.000136	0.00158	CcSEcCtD
Melatonin—Malnutrition—Docetaxel—ovarian cancer	0.000135	0.00158	CcSEcCtD
Melatonin—Erythema—Docetaxel—ovarian cancer	0.000135	0.00158	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000135	0.00157	CcSEcCtD
Melatonin—Nausea—Topotecan—ovarian cancer	0.000135	0.00157	CcSEcCtD
Melatonin—Gastritis—Epirubicin—ovarian cancer	0.000134	0.00156	CcSEcCtD
Melatonin—Dry mouth—Paclitaxel—ovarian cancer	0.000133	0.00155	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—ovarian cancer	0.000133	0.00155	CcSEcCtD
Melatonin—Nausea—Melphalan—ovarian cancer	0.000132	0.00153	CcSEcCtD
Melatonin—CYP1A1—lymph node—ovarian cancer	0.000131	0.00141	CbGeAlD
Melatonin—Back pain—Docetaxel—ovarian cancer	0.000131	0.00152	CcSEcCtD
Melatonin—Muscle spasms—Docetaxel—ovarian cancer	0.00013	0.00152	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00013	0.00151	CcSEcCtD
Melatonin—Infection—Paclitaxel—ovarian cancer	0.00013	0.00151	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—ovarian cancer	0.000129	0.0015	CcSEcCtD
Melatonin—Shock—Paclitaxel—ovarian cancer	0.000128	0.00149	CcSEcCtD
Melatonin—Dizziness—Vinorelbine—ovarian cancer	0.000128	0.00149	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000128	0.00149	CcSEcCtD
Melatonin—Nervous system disorder—Paclitaxel—ovarian cancer	0.000128	0.00149	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—ovarian cancer	0.000128	0.00149	CcSEcCtD
Melatonin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000128	0.00149	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—ovarian cancer	0.000127	0.00148	CcSEcCtD
Melatonin—Skin disorder—Paclitaxel—ovarian cancer	0.000127	0.00147	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000125	0.00146	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—ovarian cancer	0.000124	0.00145	CcSEcCtD
Melatonin—Vomiting—Vinorelbine—ovarian cancer	0.000123	0.00143	CcSEcCtD
Melatonin—Rash—Vinorelbine—ovarian cancer	0.000122	0.00142	CcSEcCtD
Melatonin—Dermatitis—Vinorelbine—ovarian cancer	0.000122	0.00142	CcSEcCtD
Melatonin—Headache—Vinorelbine—ovarian cancer	0.000121	0.00141	CcSEcCtD
Melatonin—Syncope—Docetaxel—ovarian cancer	0.000121	0.00141	CcSEcCtD
Melatonin—Leukopenia—Docetaxel—ovarian cancer	0.000121	0.00141	CcSEcCtD
Melatonin—Palpitations—Docetaxel—ovarian cancer	0.00012	0.00139	CcSEcCtD
Melatonin—Weight increased—Epirubicin—ovarian cancer	0.000119	0.00139	CcSEcCtD
Melatonin—Loss of consciousness—Docetaxel—ovarian cancer	0.000119	0.00139	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000119	0.00138	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—ovarian cancer	0.000118	0.00138	CcSEcCtD
Melatonin—Insomnia—Paclitaxel—ovarian cancer	0.000118	0.00137	CcSEcCtD
Melatonin—Paraesthesia—Paclitaxel—ovarian cancer	0.000117	0.00136	CcSEcCtD
Melatonin—Hypertension—Docetaxel—ovarian cancer	0.000117	0.00136	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—ovarian cancer	0.000117	0.00136	CcSEcCtD
Melatonin—Infestation—Epirubicin—ovarian cancer	0.000117	0.00136	CcSEcCtD
Melatonin—Somnolence—Paclitaxel—ovarian cancer	0.000116	0.00135	CcSEcCtD
Melatonin—Arthralgia—Docetaxel—ovarian cancer	0.000115	0.00134	CcSEcCtD
Melatonin—Chest pain—Docetaxel—ovarian cancer	0.000115	0.00134	CcSEcCtD
Melatonin—Nausea—Vinorelbine—ovarian cancer	0.000115	0.00134	CcSEcCtD
Melatonin—Dyspepsia—Paclitaxel—ovarian cancer	0.000115	0.00134	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000114	0.00133	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—ovarian cancer	0.000114	0.00133	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—ovarian cancer	0.000113	0.00131	CcSEcCtD
Melatonin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000113	0.00131	CcSEcCtD
Melatonin—Fatigue—Paclitaxel—ovarian cancer	0.000112	0.00131	CcSEcCtD
Melatonin—Pain—Paclitaxel—ovarian cancer	0.000111	0.0013	CcSEcCtD
Melatonin—Haematuria—Epirubicin—ovarian cancer	0.000111	0.0013	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000111	0.00129	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—ovarian cancer	0.00011	0.00129	CcSEcCtD
Melatonin—Infection—Docetaxel—ovarian cancer	0.00011	0.00128	CcSEcCtD
Melatonin—Shock—Docetaxel—ovarian cancer	0.000109	0.00127	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—ovarian cancer	0.000108	0.00126	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000108	0.00126	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—ovarian cancer	0.000108	0.00126	CcSEcCtD
Melatonin—Infestation—Doxorubicin—ovarian cancer	0.000108	0.00126	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—ovarian cancer	0.000107	0.00125	CcSEcCtD
Melatonin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000107	0.00124	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—ovarian cancer	0.000105	0.00123	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000104	0.00121	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—ovarian cancer	0.000103	0.0012	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—ovarian cancer	0.000103	0.0012	CcSEcCtD
Melatonin—Abdominal pain—Paclitaxel—ovarian cancer	0.000103	0.0012	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—ovarian cancer	0.000103	0.0012	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000102	0.00119	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000101	0.00117	CcSEcCtD
Melatonin—Insomnia—Docetaxel—ovarian cancer	9.99e-05	0.00116	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—ovarian cancer	9.92e-05	0.00116	CcSEcCtD
Melatonin—Somnolence—Docetaxel—ovarian cancer	9.82e-05	0.00114	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—ovarian cancer	9.8e-05	0.00114	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—ovarian cancer	9.74e-05	0.00113	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—ovarian cancer	9.73e-05	0.00113	CcSEcCtD
Melatonin—Hypersensitivity—Paclitaxel—ovarian cancer	9.61e-05	0.00112	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—ovarian cancer	9.59e-05	0.00112	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.54e-05	0.00111	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—ovarian cancer	9.54e-05	0.00111	CcSEcCtD
Melatonin—Fatigue—Docetaxel—ovarian cancer	9.53e-05	0.00111	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—ovarian cancer	9.52e-05	0.00111	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—ovarian cancer	9.52e-05	0.00111	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—ovarian cancer	9.48e-05	0.0011	CcSEcCtD
Melatonin—Pain—Docetaxel—ovarian cancer	9.45e-05	0.0011	CcSEcCtD
Melatonin—Asthenia—Paclitaxel—ovarian cancer	9.35e-05	0.00109	CcSEcCtD
Melatonin—Pruritus—Paclitaxel—ovarian cancer	9.22e-05	0.00107	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—ovarian cancer	9.19e-05	0.00107	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—ovarian cancer	9.13e-05	0.00106	CcSEcCtD
Melatonin—Erythema—Epirubicin—ovarian cancer	9.13e-05	0.00106	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—ovarian cancer	9.07e-05	0.00106	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—ovarian cancer	9.04e-05	0.00105	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—ovarian cancer	9.01e-05	0.00105	CcSEcCtD
Melatonin—Flatulence—Epirubicin—ovarian cancer	9e-05	0.00105	CcSEcCtD
Melatonin—Tension—Epirubicin—ovarian cancer	8.96e-05	0.00104	CcSEcCtD
Melatonin—Nervousness—Epirubicin—ovarian cancer	8.87e-05	0.00103	CcSEcCtD
Melatonin—Back pain—Epirubicin—ovarian cancer	8.83e-05	0.00103	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—ovarian cancer	8.81e-05	0.00103	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—ovarian cancer	8.78e-05	0.00102	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—ovarian cancer	8.77e-05	0.00102	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—ovarian cancer	8.74e-05	0.00102	CcSEcCtD
Melatonin—Dizziness—Paclitaxel—ovarian cancer	8.62e-05	0.001	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—ovarian cancer	8.61e-05	0.001	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—ovarian cancer	8.5e-05	0.00099	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—ovarian cancer	8.45e-05	0.000984	CcSEcCtD
Melatonin—Erythema—Doxorubicin—ovarian cancer	8.45e-05	0.000984	CcSEcCtD
Melatonin—Agitation—Epirubicin—ovarian cancer	8.39e-05	0.000977	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—ovarian cancer	8.33e-05	0.00097	CcSEcCtD
Melatonin—Tension—Doxorubicin—ovarian cancer	8.29e-05	0.000966	CcSEcCtD
Melatonin—Vomiting—Paclitaxel—ovarian cancer	8.29e-05	0.000965	CcSEcCtD
Melatonin—Rash—Paclitaxel—ovarian cancer	8.22e-05	0.000957	CcSEcCtD
Melatonin—Dermatitis—Paclitaxel—ovarian cancer	8.21e-05	0.000956	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—ovarian cancer	8.21e-05	0.000956	CcSEcCtD
Melatonin—Vertigo—Epirubicin—ovarian cancer	8.21e-05	0.000955	CcSEcCtD
Melatonin—Syncope—Epirubicin—ovarian cancer	8.19e-05	0.000954	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—ovarian cancer	8.17e-05	0.000952	CcSEcCtD
Melatonin—Back pain—Doxorubicin—ovarian cancer	8.17e-05	0.000952	CcSEcCtD
Melatonin—Headache—Paclitaxel—ovarian cancer	8.17e-05	0.000951	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—ovarian cancer	8.14e-05	0.000948	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—ovarian cancer	8.12e-05	0.000946	CcSEcCtD
Melatonin—Palpitations—Epirubicin—ovarian cancer	8.07e-05	0.00094	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—ovarian cancer	8.03e-05	0.000935	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—ovarian cancer	7.96e-05	0.000927	CcSEcCtD
Melatonin—Asthenia—Docetaxel—ovarian cancer	7.93e-05	0.000923	CcSEcCtD
Melatonin—Hypertension—Epirubicin—ovarian cancer	7.88e-05	0.000918	CcSEcCtD
Melatonin—Pruritus—Docetaxel—ovarian cancer	7.82e-05	0.00091	CcSEcCtD
Melatonin—Chest pain—Epirubicin—ovarian cancer	7.78e-05	0.000905	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—ovarian cancer	7.78e-05	0.000905	CcSEcCtD
Melatonin—Agitation—Doxorubicin—ovarian cancer	7.77e-05	0.000904	CcSEcCtD
Melatonin—Anxiety—Epirubicin—ovarian cancer	7.75e-05	0.000902	CcSEcCtD
Melatonin—Nausea—Paclitaxel—ovarian cancer	7.74e-05	0.000902	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.72e-05	0.000899	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—ovarian cancer	7.6e-05	0.000885	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—ovarian cancer	7.59e-05	0.000884	CcSEcCtD
Melatonin—Syncope—Doxorubicin—ovarian cancer	7.58e-05	0.000882	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—ovarian cancer	7.56e-05	0.000881	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—ovarian cancer	7.47e-05	0.000869	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—ovarian cancer	7.43e-05	0.000865	CcSEcCtD
Melatonin—Infection—Epirubicin—ovarian cancer	7.4e-05	0.000862	CcSEcCtD
Melatonin—Shock—Epirubicin—ovarian cancer	7.33e-05	0.000854	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—ovarian cancer	7.31e-05	0.000851	CcSEcCtD
Melatonin—Dizziness—Docetaxel—ovarian cancer	7.31e-05	0.000851	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—ovarian cancer	7.3e-05	0.00085	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—ovarian cancer	7.3e-05	0.000849	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—ovarian cancer	7.24e-05	0.000843	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—ovarian cancer	7.19e-05	0.000838	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—ovarian cancer	7.19e-05	0.000838	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—ovarian cancer	7.17e-05	0.000835	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	7.14e-05	0.000832	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—ovarian cancer	7.04e-05	0.000819	CcSEcCtD
Melatonin—Vomiting—Docetaxel—ovarian cancer	7.03e-05	0.000818	CcSEcCtD
Melatonin—Rash—Docetaxel—ovarian cancer	6.97e-05	0.000811	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—ovarian cancer	6.96e-05	0.000811	CcSEcCtD
Melatonin—Headache—Docetaxel—ovarian cancer	6.92e-05	0.000806	CcSEcCtD
Melatonin—Infection—Doxorubicin—ovarian cancer	6.85e-05	0.000798	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.79e-05	0.000791	CcSEcCtD
Melatonin—Shock—Doxorubicin—ovarian cancer	6.79e-05	0.00079	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—ovarian cancer	6.76e-05	0.000787	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—ovarian cancer	6.75e-05	0.000786	CcSEcCtD
Melatonin—Insomnia—Epirubicin—ovarian cancer	6.74e-05	0.000785	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—ovarian cancer	6.7e-05	0.00078	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—ovarian cancer	6.69e-05	0.000779	CcSEcCtD
Melatonin—Somnolence—Epirubicin—ovarian cancer	6.63e-05	0.000772	CcSEcCtD
Melatonin—Nausea—Docetaxel—ovarian cancer	6.56e-05	0.000764	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—ovarian cancer	6.56e-05	0.000764	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.43e-05	0.000749	CcSEcCtD
Melatonin—Fatigue—Epirubicin—ovarian cancer	6.43e-05	0.000748	CcSEcCtD
Melatonin—Pain—Epirubicin—ovarian cancer	6.37e-05	0.000742	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.28e-05	0.000732	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—ovarian cancer	6.24e-05	0.000726	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—ovarian cancer	6.19e-05	0.000721	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—ovarian cancer	6.13e-05	0.000714	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—ovarian cancer	6.09e-05	0.00071	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—ovarian cancer	6.07e-05	0.000707	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.95e-05	0.000693	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—ovarian cancer	5.95e-05	0.000692	CcSEcCtD
Melatonin—Pain—Doxorubicin—ovarian cancer	5.9e-05	0.000687	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—ovarian cancer	5.89e-05	0.000686	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.64e-05	0.000657	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—ovarian cancer	5.49e-05	0.000639	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—ovarian cancer	5.45e-05	0.000635	CcSEcCtD
Melatonin—Asthenia—Epirubicin—ovarian cancer	5.35e-05	0.000623	CcSEcCtD
Melatonin—Pruritus—Epirubicin—ovarian cancer	5.27e-05	0.000614	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—ovarian cancer	5.08e-05	0.000592	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—ovarian cancer	4.95e-05	0.000576	CcSEcCtD
Melatonin—Dizziness—Epirubicin—ovarian cancer	4.93e-05	0.000574	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—ovarian cancer	4.88e-05	0.000568	CcSEcCtD
Melatonin—Vomiting—Epirubicin—ovarian cancer	4.74e-05	0.000552	CcSEcCtD
Melatonin—Rash—Epirubicin—ovarian cancer	4.7e-05	0.000547	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—ovarian cancer	4.7e-05	0.000547	CcSEcCtD
Melatonin—Headache—Epirubicin—ovarian cancer	4.67e-05	0.000544	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—ovarian cancer	4.56e-05	0.000531	CcSEcCtD
Melatonin—Nausea—Epirubicin—ovarian cancer	4.43e-05	0.000515	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—ovarian cancer	4.38e-05	0.000511	CcSEcCtD
Melatonin—Rash—Doxorubicin—ovarian cancer	4.35e-05	0.000506	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—ovarian cancer	4.34e-05	0.000506	CcSEcCtD
Melatonin—Headache—Doxorubicin—ovarian cancer	4.32e-05	0.000503	CcSEcCtD
Melatonin—Nausea—Doxorubicin—ovarian cancer	4.1e-05	0.000477	CcSEcCtD
Melatonin—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.06e-06	3.03e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APC—ovarian cancer	3.05e-06	3.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CG—ovarian cancer	3.05e-06	3.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—NRAS—ovarian cancer	3.05e-06	3.02e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.04e-06	3.01e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1B—ovarian cancer	3.03e-06	3e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1B—ovarian cancer	3.03e-06	3e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PTEN—ovarian cancer	3.02e-06	2.99e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PTEN—ovarian cancer	3.02e-06	2.99e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—TYMS—ovarian cancer	3.01e-06	2.98e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CCND1—ovarian cancer	3e-06	2.97e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—AKT1—ovarian cancer	2.99e-06	2.96e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—AKT1—ovarian cancer	2.99e-06	2.96e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.97e-06	2.94e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	2.97e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—AKT1—ovarian cancer	2.97e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CTNNB1—ovarian cancer	2.96e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APC—ovarian cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CG—ovarian cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APC—ovarian cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CG—ovarian cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—NRAS—ovarian cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—NRAS—ovarian cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MAPK3—ovarian cancer	2.92e-06	2.89e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—ovarian cancer	2.91e-06	2.88e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTEN—ovarian cancer	2.89e-06	2.87e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTEN—ovarian cancer	2.89e-06	2.86e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—AKT1—ovarian cancer	2.87e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—AKT1—ovarian cancer	2.87e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CTNNB1—ovarian cancer	2.86e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CTNNB1—ovarian cancer	2.86e-06	2.84e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CAV1—ovarian cancer	2.84e-06	2.81e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.83e-06	2.81e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK3—ovarian cancer	2.83e-06	2.8e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MAPK3—ovarian cancer	2.83e-06	2.8e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CB—ovarian cancer	2.8e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—ovarian cancer	2.79e-06	2.77e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—ovarian cancer	2.79e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—ovarian cancer	2.79e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—ovarian cancer	2.79e-06	2.76e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MAPK1—ovarian cancer	2.78e-06	2.75e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—ovarian cancer	2.78e-06	2.75e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—ovarian cancer	2.73e-06	2.7e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.71e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—ovarian cancer	2.71e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—ovarian cancer	2.71e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—ovarian cancer	2.7e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—ovarian cancer	2.7e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—ovarian cancer	2.7e-06	2.67e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—ovarian cancer	2.7e-06	2.67e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MAPK1—ovarian cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK1—ovarian cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—ovarian cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—ovarian cancer	2.69e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—ovarian cancer	2.68e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK3—ovarian cancer	2.67e-06	2.64e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—ovarian cancer	2.65e-06	2.63e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—ovarian cancer	2.63e-06	2.6e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—ovarian cancer	2.63e-06	2.6e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—ovarian cancer	2.61e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—ovarian cancer	2.6e-06	2.57e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—ovarian cancer	2.6e-06	2.57e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—ovarian cancer	2.59e-06	2.56e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.58e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK3—ovarian cancer	2.58e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK3—ovarian cancer	2.58e-06	2.56e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—ovarian cancer	2.58e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—ovarian cancer	2.58e-06	2.55e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—ovarian cancer	2.57e-06	2.55e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—ovarian cancer	2.57e-06	2.54e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK1—ovarian cancer	2.54e-06	2.52e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—ovarian cancer	2.54e-06	2.52e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—ovarian cancer	2.54e-06	2.52e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—ovarian cancer	2.54e-06	2.51e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—ovarian cancer	2.5e-06	2.47e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—ovarian cancer	2.5e-06	2.47e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.49e-06	2.47e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—ovarian cancer	2.49e-06	2.47e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—ovarian cancer	2.49e-06	2.47e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK3—ovarian cancer	2.47e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK3—ovarian cancer	2.47e-06	2.44e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK1—ovarian cancer	2.46e-06	2.43e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK1—ovarian cancer	2.46e-06	2.43e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—ovarian cancer	2.46e-06	2.43e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—ovarian cancer	2.46e-06	2.43e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CAV1—ovarian cancer	2.42e-06	2.4e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—ovarian cancer	2.42e-06	2.39e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	2.41e-06	2.39e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—ovarian cancer	2.41e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—ovarian cancer	2.4e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—ovarian cancer	2.4e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK3—ovarian cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK3—ovarian cancer	2.38e-06	2.36e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—ovarian cancer	2.37e-06	2.35e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK1—ovarian cancer	2.35e-06	2.33e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—ovarian cancer	2.35e-06	2.33e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK1—ovarian cancer	2.35e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—ovarian cancer	2.35e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	2.34e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MTOR—ovarian cancer	2.34e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—ovarian cancer	2.34e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—ovarian cancer	2.34e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	2.33e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	2.33e-06	2.31e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—ovarian cancer	2.32e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—ovarian cancer	2.32e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—ovarian cancer	2.32e-06	2.3e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—ovarian cancer	2.32e-06	2.3e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.32e-06	2.29e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—ovarian cancer	2.29e-06	2.27e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—ovarian cancer	2.29e-06	2.27e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—ovarian cancer	2.29e-06	2.27e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK1—ovarian cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK1—ovarian cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—ovarian cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—ovarian cancer	2.27e-06	2.25e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MTOR—ovarian cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MTOR—ovarian cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	2.26e-06	2.24e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—ovarian cancer	2.25e-06	2.22e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—ovarian cancer	2.23e-06	2.21e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—ovarian cancer	2.23e-06	2.21e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—ovarian cancer	2.22e-06	2.2e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—ovarian cancer	2.22e-06	2.19e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.21e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—ovarian cancer	2.2e-06	2.18e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	2.19e-06	2.17e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—ovarian cancer	2.17e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—ovarian cancer	2.17e-06	2.15e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.17e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—ovarian cancer	2.16e-06	2.14e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—ovarian cancer	2.16e-06	2.14e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—ovarian cancer	2.15e-06	2.13e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—ovarian cancer	2.15e-06	2.13e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—ovarian cancer	2.15e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—ovarian cancer	2.14e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—ovarian cancer	2.14e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—ovarian cancer	2.14e-06	2.12e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—ovarian cancer	2.13e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—ovarian cancer	2.13e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	2.12e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	2.12e-06	2.1e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—ovarian cancer	2.09e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—ovarian cancer	2.08e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—ovarian cancer	2.08e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—ovarian cancer	2.08e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—ovarian cancer	2.08e-06	2.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	2.07e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—ovarian cancer	2.07e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—ovarian cancer	2.07e-06	2.05e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	2.04e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—ovarian cancer	2.04e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—ovarian cancer	2.04e-06	2.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—ovarian cancer	2.03e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—ovarian cancer	2.03e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—ovarian cancer	2.03e-06	2e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—ovarian cancer	2.02e-06	2e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	2.01e-06	1.99e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	2.01e-06	1.99e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.98e-06	1.96e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—ovarian cancer	1.98e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—ovarian cancer	1.97e-06	1.95e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—ovarian cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—ovarian cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—ovarian cancer	1.95e-06	1.93e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.94e-06	1.92e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—ovarian cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—ovarian cancer	1.91e-06	1.89e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—ovarian cancer	1.89e-06	1.87e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—ovarian cancer	1.89e-06	1.87e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—ovarian cancer	1.89e-06	1.87e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—ovarian cancer	1.88e-06	1.86e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—ovarian cancer	1.88e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—ovarian cancer	1.82e-06	1.81e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—ovarian cancer	1.82e-06	1.8e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—ovarian cancer	1.82e-06	1.8e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—ovarian cancer	1.81e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—ovarian cancer	1.81e-06	1.79e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—ovarian cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—ovarian cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—ovarian cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—ovarian cancer	1.77e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—ovarian cancer	1.77e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—ovarian cancer	1.75e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—ovarian cancer	1.75e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—ovarian cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—ovarian cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—ovarian cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—ovarian cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—ovarian cancer	1.74e-06	1.72e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—ovarian cancer	1.74e-06	1.72e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK3—ovarian cancer	1.73e-06	1.71e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—ovarian cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—ovarian cancer	1.7e-06	1.69e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.69e-06	1.67e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—ovarian cancer	1.68e-06	1.66e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK3—ovarian cancer	1.67e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK3—ovarian cancer	1.67e-06	1.65e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—ovarian cancer	1.67e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—ovarian cancer	1.66e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—ovarian cancer	1.65e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—ovarian cancer	1.65e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK1—ovarian cancer	1.64e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—ovarian cancer	1.64e-06	1.63e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—ovarian cancer	1.62e-06	1.61e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—ovarian cancer	1.62e-06	1.61e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—ovarian cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—ovarian cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK1—ovarian cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK1—ovarian cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—ovarian cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—ovarian cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—ovarian cancer	1.55e-06	1.54e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—ovarian cancer	1.5e-06	1.49e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—ovarian cancer	1.5e-06	1.49e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—ovarian cancer	1.46e-06	1.45e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—ovarian cancer	1.39e-06	1.38e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—ovarian cancer	1.38e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	1.38e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	1.38e-06	1.37e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—ovarian cancer	1.35e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—ovarian cancer	1.35e-06	1.33e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—ovarian cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—ovarian cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—ovarian cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—ovarian cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—ovarian cancer	1.28e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—ovarian cancer	1.28e-06	1.26e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—ovarian cancer	1.26e-06	1.25e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—ovarian cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—ovarian cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.21e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—ovarian cancer	1.16e-06	1.15e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—ovarian cancer	1.13e-06	1.12e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—ovarian cancer	1.13e-06	1.12e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—ovarian cancer	1.08e-06	1.07e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—ovarian cancer	9.86e-07	9.76e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—ovarian cancer	8.43e-07	8.34e-06	CbGpPWpGaD
